Across TCGA pan-cancer cohorts, COL1A2 RNA is linked to patient survival in 25 of 34 cancer types, making it the most broadly survival-associated COL1A2 data layer compared with 11 for mutation status and 5 for mass-spec protein.
The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher COL1A2 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated COL1A2 expression acts as an unfavorable survival marker, although some lineages such as UCS and DLBC show a favorable association.
KIRP, MESO, and BLCA are the cancer types where COL1A2 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.